HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Normalisation of refractive error after steroid injection for adnexal haemangiomas.

Abstract
A longitudinal study of 27 patients with infantile haemangiomas is reported. It confirmed the efficacy of local steroid injection as a method of treatment; 81.5% of patients showed a marked improvement, with the lesion reducing to 25% or less of its original size. Involution was most marked in the first two weeks but continued for up to four months after injection. Amblyopia was present in 43% of children and was usually the result of induced refractive error rather than obstruction of the visual axis or strabismus. Anisometropia was found in 68% of children, with a high incidence of asymmetric astigmatism on the side of the haemangioma. Following local steroid injection a marked reduction in astigmatism was noted in 53.8% of children, a lesser reduction in 15.4%, and no reduction in 30.8%. Successful treatment of the haemangioma, therefore, may not remove the risk of amblyopia, and regular refraction and visual assessment remain mandatory.
AuthorsA J Morrell, H E Willshaw
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 75 Issue 5 Pg. 301-5 (May 1991) ISSN: 0007-1161 [Print] England
PMID2036349 (Publication Type: Journal Article)
Chemical References
  • Triamcinolone
  • Dexamethasone
Topics
  • Adolescent
  • Amblyopia (etiology)
  • Astigmatism (prevention & control)
  • Child, Preschool
  • Dexamethasone (administration & dosage)
  • Drug Therapy, Combination
  • Eyelid Neoplasms (complications, drug therapy)
  • Female
  • Hemangioma (complications, drug therapy)
  • Humans
  • Infant
  • Injections, Intralesional
  • Longitudinal Studies
  • Male
  • Refractive Errors (etiology, prevention & control)
  • Triamcinolone (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: